Use your antibodies-online credentials, if available.
Angiostatin is an angiogenesis inhibitor that blocks neovascularization and growth of experimental primary and metastatic tumors in vivo. 再加上，我们可以发Angiostatin 试剂盒 (42) 和 Angiostatin 蛋白 (10)和数多这个蛋白质的别的产品。
Showing 10 out of 31 products:
Human Monoclonal ANG Primary Antibody for IP, WB - ABIN967561
Fidler: Cancer metastasis. in British medical bulletin 1991
Show all 2 Pubmed References
confirmed the ability of Plg (显示 PLG 抗体)/Pla to both promote efferocytosis and override the prosurvival effect of LPS (显示 TLR4 抗体) via annexin A1 (显示 ANXA1 抗体).
findings identify plasmin (显示 PLG 抗体) as a decisive checkpoint in the inflammatory response during Macrophage activation syndrome (MAS (显示 MAS1 抗体)) and a potential novel therapeutic target for MAS (显示 MAS1 抗体).
Deficiency of plasminogen (显示 PLG 抗体) delays onset of autoimmune neuroinflammatory disease and protects from the development of paralysis.
Plasminogen (显示 PLG 抗体) may regulate DPP-4 (显示 DPP4 抗体) activity and glucose metabolism.
Plasminogen (显示 PLG 抗体)-deficient mice frequently develop colon lesions and rectal prolapses.
manganese transport protein (显示 SLC11A2 抗体) C (显示 PROC 抗体) (MntC) is an extracellular matrix- and plasminogen-binding protein (显示 ENO1 抗体)
Plg (显示 PLG 抗体) from mouse plasma contains oxPtdPC adducts that are not affected by the action of Lp-PLA(2 (显示 Lp-PLA2 抗体)), suggesting that linkage to Plg (显示 PLG 抗体) protects oxPtdPCs from metabolism during their transport in the plasma.
plg (显示 PLG 抗体)-/- and tPA (显示 PLAT 抗体)-/- mice exhibit brain parenchymal fibrin deposits that appear to result from reduced neurovascular integrity
plasminogen (显示 PLG 抗体)-dependent proteolysis has a beneficial effect during neurological recovery after stroke.
Pla-induced mononuclear cell recruitment in vivo was dependent on protease-activated receptor-1 activation of the MEK/ERK/NF-kappaB pathway, which led to the release of CCL2 and activation of CCR2.
Angiostatin is an angiogenesis inhibitor that blocks neovascularization and growth of experimental primary and metastatic tumors in vivo. Plasmin dissolves the fibrin of blood clots and acts as a proteolytic factor in a variety of other processes including embryonic development, tissue remodeling, tumor invasion, and inflammation. In ovulation, weakens the walls of the Graafian follicle. It activates the urokinase-type plasminogen activator, collagenases and several complement zymogens, such as C1 and C5. Cleavage of fibronectin and laminin leads to cell detachment and apoptosis. Also cleaves fibrin, thrombospondin and von Willebrand factor. Its role in tissue remodeling and tumor invasion may be modulated by CSPG4. Binds to cells (By similarity).
, plasmin heavy chain A
, plasmin light chain B